Patients voice concern about consequences of a Genzyme takeover

08/9/2010 | Boston Globe (tiered subscription model), The

Some patients who use Genzyme's treatments are worried that their close relationship with the biotech firm will end if it is acquired by a bigger company. Meanwhile, Genzyme's strategy of reaching out and regularly checking on patients has prompted other drug companies to try the same to expand their share of the market for rare illnesses, such as Pompe and Gaucher diseases.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR